These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy]. Krasil'nikov VV; Labeznik TA; Shilov LA Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468 [TBL] [Abstract][Full Text] [Related]
23. Duchenne's muscular dystrophy: the electrocardiogram in female relatives. Mann O; DeLeon AC; Perloff JK; Simanis J; Horrigan FD Am J Med Sci; 1968 Jun; 255():376-81. PubMed ID: 5654956 [No Abstract] [Full Text] [Related]
24. Creatine-phosphokinase (CPK) activity in relatives of patients with X-linked muscular dystrophies: a Brazilian study. Zatz M; Frota-Pessoa O; Levy JA; Peres CA J Genet Hum; 1976 Jun; 24(2):153-68. PubMed ID: 965952 [TBL] [Abstract][Full Text] [Related]
25. Quantitative measurements in female siblings and mothers of boys with Duchenne dystrophy. Fowler WM; Gardner GW; Taylor RG; Scavarda A; Busheikin JB Arch Phys Med Rehabil; 1969 Jun; 50(6):301-10. PubMed ID: 5788486 [No Abstract] [Full Text] [Related]
26. The significance of changes in the blood serum electrolytes in the detection of heterozygous carriers of Duchenne myopathy. Grinio LP Sov Genet; 1974 Mar; 7(12):1596-9. PubMed ID: 4827770 [No Abstract] [Full Text] [Related]
27. Carrier detection in the Duchenne type muscular dystrophy: preliminary observations on the place of electromyography. Jacobs K J Neurol Sci; 1968; 6(2):347-56. PubMed ID: 5707432 [No Abstract] [Full Text] [Related]
28. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy. Zatz M; Passos MR; Bortolini ER Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115 [No Abstract] [Full Text] [Related]
30. Creatine phospholinase in normal neonates and young infants. Bodensteiner JB; Zellweger H J Lab Clin Med; 1971 May; 77(5):853-8. PubMed ID: 5557668 [No Abstract] [Full Text] [Related]
31. Carrier detection and genetic counselling in Duchenne dystrophy. Dubowitz V Dev Med Child Neurol; 1975 Jun; 17(3):352-6. PubMed ID: 1107098 [No Abstract] [Full Text] [Related]
32. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy. Lange K; Zatz M Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274 [TBL] [Abstract][Full Text] [Related]
33. Benign muscular dystrophy: risk calculation in families with consanguinity. Wolff G; Müller CR; Grimm T J Med Genet; 1989 May; 26(5):299-304. PubMed ID: 2732990 [TBL] [Abstract][Full Text] [Related]
34. [X-linked muscular dystrophy: is prevention possible?]. Plauchu H Pediatrie; 1990; 45(5):297-9. PubMed ID: 2165239 [No Abstract] [Full Text] [Related]
35. Quantitative electromyography: carrier detection in Duchenne type muscular dystrophy using a new automatic technique. Moosa A; Brown BH; Dubowitz V J Neurol Neurosurg Psychiatry; 1972 Dec; 35(6):841-4. PubMed ID: 4647857 [TBL] [Abstract][Full Text] [Related]
39. [A benign recessiv X-chromosomal hereditary muscular dystrophy. II. Examinations of female carriers]. Rotthauwe HW; Kowalewski S Humangenetik; 1966; 3(1):30-40. PubMed ID: 5986053 [No Abstract] [Full Text] [Related]
40. The linkage relations of the loci for benign (Becker type) X-borne muscular dystrophy, colour blindness and the Xg blood groups. Emery AE; Smith CA; Sanger R Ann Hum Genet; 1969 Jan; 32(3):261-9. PubMed ID: 5305175 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]